In EDS ansehen

Extracellular Vesicle Mitochondrial DNA Levels Are Associated With Chronic Kidney Disease and Mitochondrial Haplogroup in Obese Individuals

Gespeichert in:
Bibliographische Detailangaben
Titel: Extracellular Vesicle Mitochondrial DNA Levels Are Associated With Chronic Kidney Disease and Mitochondrial Haplogroup in Obese Individuals
Autoren: Jaida E. Morgan, Nicole Noren Hooten, Nicolle A. Mode, Ngozi Ezike, Alan B. Zonderman, Michele K. Evans
Quelle: J Extracell Biol
Journal of Extracellular Biology, Vol 4, Iss 7, Pp n/a-n/a (2025)
Verlagsinformationen: Wiley, 2025.
Publikationsjahr: 2025
Schlagwörter: QH573-671, ancestry, circulating cell‐free mitochondrial DNA, exosomes, ccf‐mtDNA, Cytology, EVs, chronic kidney disease, Research Article
Beschreibung: Chronic kidney disease (CKD) and obesity are major chronic diseases in the United States. Although obesity is a risk factor for CKD, little is known about how obesity contributes to CKD. Due to their role as intercellular communicators, extracellular vesicles (EVs) may be a factor connecting obesity and CKD. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA), a damage‐associated molecular pattern molecule associated with inflammation, is associated with renal disease and may be encapsulated within EVs. In this longitudinal study, we isolated plasma EVs and analysed EV mtDNA levels in a cohort of African American and White obese middle‐aged individuals who at visit 1 did not have CKD but developed CKD by visit 2 (n = 19; CKD group) and matched this group to controls who did not develop CKD by visit 2 (n = 56; control group). In our cross‐sectional analyses at visit 1, we found significant interactions for EV mtDNA levels between race and CKD status, poverty status and CKD status, and sex and CKD status. EV mtDNA levels were significantly lower in participants within the African haplogroup who developed CKD compared to participants within the European haplogroup who developed CKD and the African haplogroup control group. In our longitudinal analyses using data from both visit 1 and visit 2, individuals who developed CKD had lower EV mtDNA levels. Stratification by haplogroup showed that among participants within the African haplogroup, those who developed CKD had significantly lower EV mtDNA levels than those in the control group. In conclusion, EV mtDNA levels were lower in individuals who develop CKD. Our findings demonstrate that CKD status and mtDNA haplogroup influence EV cargo in obese individuals.
Publikationsart: Article
Other literature type
Sprache: English
ISSN: 2768-2811
DOI: 10.1002/jex2.70069
Zugangs-URL: https://doaj.org/article/fe273fa884434eb38a157696370c9579
Rights: CC BY NC
Dokumentencode: edsair.doi.dedup.....2ea25879b2c4922b0332c4d98a6f9ba1
Datenbank: OpenAIRE
Beschreibung
Abstract:Chronic kidney disease (CKD) and obesity are major chronic diseases in the United States. Although obesity is a risk factor for CKD, little is known about how obesity contributes to CKD. Due to their role as intercellular communicators, extracellular vesicles (EVs) may be a factor connecting obesity and CKD. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA), a damage‐associated molecular pattern molecule associated with inflammation, is associated with renal disease and may be encapsulated within EVs. In this longitudinal study, we isolated plasma EVs and analysed EV mtDNA levels in a cohort of African American and White obese middle‐aged individuals who at visit 1 did not have CKD but developed CKD by visit 2 (n = 19; CKD group) and matched this group to controls who did not develop CKD by visit 2 (n = 56; control group). In our cross‐sectional analyses at visit 1, we found significant interactions for EV mtDNA levels between race and CKD status, poverty status and CKD status, and sex and CKD status. EV mtDNA levels were significantly lower in participants within the African haplogroup who developed CKD compared to participants within the European haplogroup who developed CKD and the African haplogroup control group. In our longitudinal analyses using data from both visit 1 and visit 2, individuals who developed CKD had lower EV mtDNA levels. Stratification by haplogroup showed that among participants within the African haplogroup, those who developed CKD had significantly lower EV mtDNA levels than those in the control group. In conclusion, EV mtDNA levels were lower in individuals who develop CKD. Our findings demonstrate that CKD status and mtDNA haplogroup influence EV cargo in obese individuals.
ISSN:27682811
DOI:10.1002/jex2.70069